Evaluation of NICOM (Bioreactance) for the Non-invasive Determination of Cardiac Output

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02331329

Enrollment

Registered

2015-01-06

Start date

2013-07-31

Completion date

2014-06-30

Last updated

2015-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Disease

Keywords

Accuracy of NICOM, precision of NICOM

Brief summary

Cardiac output (CO) is an important parameter in the diagnosis and therapy of cardiac diseases. The current standard methods for the determination of CO, however, are either invasive (e.g. right heart catheterization) or technically expendable and expensive (magnetic resonance tomography, MRT). Therefore, the aim of the study at hand was to evaluate NICOM (bioreactance) as a new method for determinion of CO and to compare this new technique to MRT.

Interventions

DEVICENICOM cardiac output measurement

DEVICECardiac MRT cardiac output measurement

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* indication for cardiac magnetic resonance imaging

Exclusion criteria

* pace maker * patient unwilling to participate

Design outcomes

Primary

Measure	Time frame
agreement of NICOM and MRT cardiac output measurements	at time of inclusion
precision of NICOM cardiac output measurements	at time of inclusion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026